Co-development of a new medicinal product
| Reference number | |
| Coordinator | ZuLa Diagnostics AB |
| Funding from Vinnova | SEK 25 000 |
| Project duration | September 2018 - December 2018 |
| Status | Completed |
Purpose and goal
We have had several B2B meetings in Beijing, Nanjing and Shanghai. This has given us some good contacts for further discussions and potential collaboration.
Expected results and effects
We are looking forward to have visitors from Nanjing coming to Stockholm to continue discussions before the end of the year.
Planned approach and implementation
Keep the discussions going on-line and prepare for the visit to Stockholm.